Riverpoint Wealth Management Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,397
Closed -$345K 54
2023
Q3
$345K Sell
10,397
-783
-7% -$27.7K 0.11% 40
2023
Q2
$410K Buy
11,180
+79
+0.7% +$3.08K 0.13% 34
2023
Q1
$453K Buy
11,101
+104
+0.9% +$4.49K 0.16% 33
2022
Q4
$563K Buy
10,997
+82
+0.8% +$3.93K 0.21% 28
2022
Q3
$478K Buy
10,915
+64
+0.6% +$3.11K 0.2% 29
2022
Q2
$569K Sell
10,851
-150
-1% -$7.64K 0.23% 26
2022
Q1
$570K Buy
11,001
+87
+0.8% +$4.51K 0.2% 27
2021
Q4
$644K Buy
10,914
+100
+0.9% +$4.96K 0.22% 27
2021
Q3
$465K Sell
10,814
-1,950
-15% -$86.4K 0.16% 41
2021
Q2
$500K Buy
12,764
+96
+0.8% +$3.73K 0.14% 58
2021
Q1
$459K Sell
12,668
-1,491
-11% -$52.9K 0.14% 57
2020
Q4
$521K Buy
14,159
+4
+0% +$147 0.16% 52
2020
Q3
$493K Buy
14,155
+88
+0.6% +$3.08K 0.18% 49
2020
Q2
$436K Buy
+14,067
New +$478K 0.17% 49
2020
Q1
Sell
-6,242
Closed -$232K 72
2019
Q4
$232K Buy
+6,242
New +$222K 0.09% 70
2019
Q1
Sell
-6,494
Closed -$269K 67
2018
Q4
$269K Sell
6,494
-63
-1% -$2.62K 0.15% 55
2018
Q3
$276K Sell
6,557
-98
-1% -$3.77K 0.14% 53
2018
Q2
$229K Buy
+6,655
New +$227K 0.13% 53

Other funds holding PFE

Riverpoint Wealth Management Holdings's PFE Position: Q4 2023 in Review

Riverpoint Wealth Management Holdings sold out of Pfizer (PFE) in Q4 2023, closing a stake of 10,397 shares — an estimated $345K sold.

Riverpoint Wealth Management Holdings first reported a position in PFE in Q2 2018 and held it in 18 quarters. The position peaked at $644K in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Riverpoint Wealth Management Holdings reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Riverpoint Wealth Management Holdings sold 10,397 Pfizer shares in Q4 2023, an estimated $345K.
  • Riverpoint Wealth Management Holdings first reported a position in Pfizer in Q2 2018 and held it in 18 quarters.
  • Riverpoint Wealth Management Holdings's Pfizer position peaked at $644K in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Riverpoint Wealth Management Holdings's 13F filing for Q4 2023, filed 6 Feb 2024.